Last but not least, the great added interest of KN-040 is to have confirmed a biomarker which is predictive of efficacy and survival: the combined positive score (CPS) of the PD-L1 expression, whereas the tumor proportion score (TPS) with a 1% cut-off of CHECKMATE-141 is not. The gene discussed is CD274; the disease is neoplasm.